Fresenius Kabi is focused on bringing the benefits of biosimilars to healthcare providers and patients in the U.S. Our comprehensive portfolio of high-quality medicines has been developed with comparable efficacy, safety, and immunogenicity to their reference products.
Our portfolio of biosimilars stands apart because it is powered end to end with our research and development expertise, optimized and sustainable manufacturing, integrated supply capabilities, and commercial know-how.
